Biotechnology Stocks I Performance Guide: BeiGene, Ltd. (BGNE)
BGNE has no dividends
Table and Chart of BGNE Performance
See what a $1,000 investment in BGNE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BGNE Returns | |
|---|---|
| Start Date | Mar-31-2016 |
| Start Price | $29.31 |
| End Date | Dec-01-2023 |
| End Price | $187.49 |
| # Prices | 94 |
| Min Date | Jul-29-2016 |
| Min Price | $26.24 |
| Max Date | Sep-30-2021 |
| Max Price | $363.00 |
| Total Return | 539.68% |
| Annualized Return | 26.73% |
| Current Value of $1,000 Purchase | $6,397 |
| Number Returns | 4,371 |
| Average Return | 175.40% |
| Number Profitable Returns | 3,432 |
| Percent Profitable Returns | 78.52% |
| Number Unprofitable Returns | 939 |
| Percent Unprofitable Returns | 21.48% |
| Profitable to Unprofitable Returns Ratio | 3.65 |
| BGNE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $20,428,349,000 | Price to Sales | 9.27 |
| Earnings per Share | $-9.2200 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 5.19 |
| PRICE DATA | |
| 52 Week High | $280.62 |
| 52 Week Low | $156.56 |
| Analyst Target Price | $286.55 |
| 50-Day Moving Average | $181.97 |
| 200-Day Moving Average | $208.56 |
| FINANCIAL DATA | |
| Revenue per Share | $21.13 |
| Revenue | $2,204,465,000 |
| Profit Margin | -43.5% |
| Return on Equity | -0.228% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BGNE Compare Returns with S&P 500
BGNE Trendline Chart